|
| |
| | | 67046 | | 11.08.2020 | | Bristol-Myers Squibb SA | | | | | | | | | | | | | 01.99. | | | | 01.99. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Zeposia 0.23 mg | Hartkapseln | Kapseln (Ozanimodum 0.23 mg) | L04AE02 | PI | | 02 | Zeposia 0.46 mg | Hartkapseln | Kapseln (Ozanimodum 0.46 mg) | L04AE02 | | | 03 | Zeposia 0.92 mg | Hartkapseln | Kapseln (Ozanimodum 0.92 mg) | L04AE02 | |
|
|
|
